Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7158 p109-114
28 July 2001

This article
Reprint
Photocopy


News summary


New malaria prophylaxis guidelines welcomed

The publication of new guidelines concerning malaria prophylaxis (PJ, 21 July, p92) has been welcomed by Dr Larry Goodyer, head of pharmacy practice at King’s College, London, and superintendent of Nomad Travel Pharmacy.

Dr Goodyer told The Journal that the new guidelines clarify what was becoming a somewhat confusing picture with regard to recommending malaria chemoprophylaxis. He added: “Although [the guidelines] are in broad agreement with the current British National Formulary, pharmacists should note that some discrepancies do exist between the two.” For instance, Malarone is licensed for up to 28 days’ use, whereas the BNF recommends that it can be used for up to three months.

This discrepancy is because Malarone received its licence for use in malaria prophylaxis after the current edition of the BNF was pulished.

Dr Goodyer also pointed out that the BNF makes some recommendations on the maximum periods for taking doxycycline (three months) and chloroquine/proguanil (five years), as well as the possibility of starting these regimens less than a week before travel in some circumstances. These points are not referred to in the guidelines. “Hopefully future editions of the BNF will clear this up,” he said.

Dr Goodyer was disappointed that travellers are still recommended to impregnate clothing with DEET by dipping the clothes in a dilution of DEET. “This is a very messy procedure, will only last a maximum of five days, and, in my experience, is rarely undertaken by travellers.” Dr Goodyer recommends that clothing should be treated with permethrin, in addition to using a repellent on the exposed skin.

He would also like to see further clarification on Table 7 and Table 8 of the new guidelines, as they do not always give alternative regimens. In response to Dr Goodyer’s request for clarification, Professor Bradley, one of the authors of the new guidelines said that travellers who could not take the recommended regimen, and for whom there was no alternative regimen given, should consult a physician or specialist travel clinic.

With regard to upper time limits being set for taking malaria prophylaxis, he added: “There is considerable difficulty in setting an upper time limit for prophylactic antimalarials in practice as good data are scarce. The guidelines were therefore cautious over this.”

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal